Ho, Ken K. Y.

Consensus on diagnosis and management of Cushing's disease: a guideline update

Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 953

Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review

Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 822

Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia

Ho, K. K. Y., & _, _. (2007) · European Journal of Endocrinology

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 615

Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women

WEISSBERGER, A. J., HO, K. K. Y., & LAZARUS, L. (1991) · The Journal of Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsMenopause: Health Impacts and Treatments

Cited by 514

Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement

Petersenn, S., Fleseriu, M., Casanueva, F. F., Giustina, A., Biermasz, N., Biller, B. M. K., Bronstein, M., Chanson, P., Fukuoka, H., Gadelha, M., et al. (2023) · Nature Reviews Endocrinology

Pituitary Gland Disorders and TreatmentsNeuroendocrine Tumor Research Advances

Cited by 411

Diagnosis of growth-hormone deficiency in adults

Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 386

Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2

Leung, K. C., Doyle, N., Ballesteros, M., Sjogren, K., Watts, C. K. W., Low, T. H., Leong, G. M., Ross, R. J. M., & Ho, K. K. Y. (2003) · Proceedings of the National Academy of Sciences

Growth Hormone and Insulin-like Growth FactorsCytokine Signaling Pathways and Interactions

Cited by 218

The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.

O'Sullivan, A. J., Crampton, L. J., Freund, J., & Ho, K. K. (1998) · Journal of Clinical Investigation

Menopause: Health Impacts and TreatmentsGrowth Hormone and Insulin-like Growth Factors

Cited by 210

Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization

Weissberger, A. J., & Ho, K. K. (1993) · The Journal of Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsHormonal and reproductive studies

Cited by 185

Effect of Octreotide, a Somatostatin Analog, on Sleep Apnea in Patients with Acromegaly

Grunstein, R. R., Ho, K. K. Y., & Sullivan, C. E. (1994) · Annals of Internal Medicine

Pituitary Gland Disorders and TreatmentsObstructive Sleep Apnea Research

Cited by 134

The Effects of Growth Hormone on Body Composition and Physical Performance in Recreational Athletes: A Randomized Trial

Meinhardt, U., Nelson, A. E., Hansen, J. L., Birzniece, V., Clifford, D., Leung, K.-C., Graham, K., & Ho, K. K. Y. (2010) · Annals of Internal Medicine

Growth Hormone and Insulin-like Growth FactorsDoping in Sports

Cited by 127

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

Boguszewski, M. C. S., Boguszewski, C. L., Chemaitilly, W., Cohen, L. E., Gebauer, J., Higham, C., Hoffman, A. R., Polak, M., Yuen, K. C. J., Alos, N., et al. (2022) · European Journal of Endocrinology

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 117

Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women

Wolthers, T., Hoffman, D. M., Nugent, A. G., Duncan, M. W., Umpleby, M., & Ho, K. K. Y. (2001) · American Journal of Physiology-Endocrinology and Metabolism

Growth Hormone and Insulin-like Growth FactorsHormonal and reproductive studies

Cited by 114

Sex steroids and the GH axis: implications for the management of hypopituitarism

Birzniece, V., & Ho, K. K. Y. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 65

Associations of insulin‐like growth factor‐I and its binding proteins and testosterone with frailty in older men

Yeap, B. B., Paul Chubb, S. A., Lopez, D., Ho, K. K. Y., Hankey, G. J., & Flicker, L. (2013) · Clinical Endocrinology

Frailty in Older AdultsHormonal and reproductive studies

Cited by 53

Comparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient women

Gibney, J., Johannsson, G., Leung, K.-C., & Ho, K. K. Y. (2005) · The Journal of Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsEstrogen and related hormone effects

Cited by 40

Protein metabolism in glucocorticoid excess: study in Cushing’s syndrome and the effect of treatment

Burt, M. G., Gibney, J., & Ho, K. K. Y. (2007) · American Journal of Physiology-Endocrinology and Metabolism

Pituitary Gland Disorders and TreatmentsMuscle metabolism and nutrition

Cited by 38

Growth hormone should be used only for approved indications

Clemmons, D. R., Molitch, M., Hoffman, A. R., Klibanski, A., Strasburger, C. J., Kleinberg, D. L., Ho, K., Webb, S. M., Bronstein, M. D., Bouillon, R., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 23

Neuroendocrine Regulation of Growth Hormone and Androgen Axes by Selective Estrogen Receptor Modulators in Healthy Men

Birzniece, V., Sata, A., Sutanto, S., & Ho, K. K. Y. (2010) · The Journal of Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsEstrogen and related hormone effects

Cited by 22

Estrogen receptor antagonism uncovers gender-dimorphic suppression of whole body fat oxidation in humans: differential effects of tamoxifen on the GH and gonadal axes

Birzniece, V., & Ho, K. K. Y. (2015) · European Journal of Endocrinology

Growth Hormone and Insulin-like Growth FactorsEstrogen and related hormone effects

Cited by 8